Physician profile
Edward Lee
NPI 1487739785
$2,247.54
in general payments reported to CMS, 2019-2025
11 companies · $72.25 in 2025
The $72.25 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,879 · 2020: $22.47 · 2021: $16.04 · 2022: $137 · 2023: $45.33 · 2024: $75.86 · 2025: $72.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $193.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $1,854.00 | 2019 | |
| Stryker Corporation | $74.45 | 2022 | |
| Medtronic, INC. | $72.25 | 2025 | Inceptiv |
| Novartis Pharmaceuticals Corporation | $69.90 | 2023-2024 | |
| Davol INC. | $48.67 | 2022 | |
| Galderma Laboratories, L.P. | $37.26 | 2024 | Dysport |
| Arthrosurface Incorporated | $24.67 | 2019 | |
| Smith+Nephew, INC. | $22.47 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.04 | 2021 | |
| Depuy Synthes Sales INC. | $14.03 | 2023 | Monovisc, Orthovisc |
| Ermi LLC | $13.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.